ACADIA PHARMACEUTICALS INC. Shares Outstanding (Cover Page)
ACADIA PHARMACEUTICALS INC. (ACAD) had Shares Outstanding (Cover Page) of 172.31 million shares as of 2026-07-28, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-28: Entity Common Stock, Shares Outstanding 172.31M shares.
- 2026-04-29: Entity Common Stock, Shares Outstanding 171.24M shares.
- 2026-02-18: Entity Common Stock, Shares Outstanding 170.49M shares.
- 2025-10-29: Entity Common Stock, Shares Outstanding 169.18M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-28 | 172.31M shares 10-Q · filed 2026-08-05 |
| 2026-04-29 | 171.24M shares 10-Q · filed 2026-05-07 |
| 2026-02-18 | 170.49M shares 10-K · filed 2026-02-26 |
| 2025-10-29 | 169.18M shares 10-Q · filed 2025-11-06 |
| 2025-07-30 | 168.71M shares 10-Q · filed 2025-08-07 |
| 2025-04-30 | 167.36M shares 10-Q · filed 2025-05-08 |
| 2025-02-18 | 166.79M shares 10-K · filed 2025-02-27 |
| 2024-10-29 | 166.39M shares 10-Q · filed 2024-11-07 |
| 2024-07-31 | 165.88M shares 10-Q · filed 2024-08-07 |
| 2024-04-30 | 165.22M shares 10-Q · filed 2024-05-09 |
| 2024-02-21 | 164.77M shares 10-K · filed 2024-02-28 |
| 2023-10-25 | 164.18M shares 10-Q · filed 2023-11-03 |
| 2023-07-26 | 163.73M shares 10-Q · filed 2023-08-03 |
| 2023-04-26 | 162.63M shares 10-Q · filed 2023-05-08 |
| 2023-02-21 | 162.23M shares 10-K · filed 2023-02-28 |
| 2022-10-21 | 161.93M shares 10-Q · filed 2022-11-03 |
| 2022-07-28 | 161.84M shares 10-Q · filed 2022-08-09 |
| 2022-04-28 | 161.43M shares 10-Q · filed 2022-05-05 |
| 2022-02-15 | 161.20M shares 10-K · filed 2022-03-01 |
| 2021-10-25 | 160.76M shares 10-Q · filed 2021-11-09 |
| 2021-07-28 | 160.64M shares 10-Q · filed 2021-08-05 |
| 2021-04-27 | 160.18M shares 10-Q · filed 2021-05-06 |
| 2021-02-10 | 160.05M shares 10-K · filed 2021-02-25 |
| 2020-10-22 | 158.98M shares 10-Q · filed 2020-11-04 |
| 2020-07-22 | 157.68M shares 10-Q · filed 2020-08-06 |
| 2020-04-22 | 155.72M shares 10-Q · filed 2020-05-08 |
| 2020-01-31 | 155.34M shares 10-K · filed 2020-02-27 |
| 2019-10-23 | 154.03M shares 10-Q · filed 2019-10-31 |
| 2019-07-24 | 144.49M shares 10-Q · filed 2019-08-01 |
| 2019-04-24 | 144.17M shares 10-Q · filed 2019-05-02 |
| 2019-01-31 | 143.88M shares 10-K · filed 2019-02-27 |
| 2018-10-31 | 125.07M shares 10-Q · filed 2018-11-06 |
| 2018-07-31 | 125.01M shares 10-Q · filed 2018-08-08 |
| 2018-04-30 | 124.83M shares 10-Q · filed 2018-05-04 |
| 2018-01-31 | 124.70M shares 10-K · filed 2018-02-27 |
| 2017-10-31 | 124.21M shares 10-Q · filed 2017-11-07 |
| 2017-07-31 | 122.40M shares 10-Q · filed 2017-08-08 |
| 2017-05-03 | 122.05M shares 10-Q · filed 2017-05-09 |
| 2017-01-31 | 121.41M shares 10-K · filed 2017-02-28 |
| 2016-10-31 | 121.11M shares 10-Q · filed 2016-11-07 |
| 2016-07-29 | 114.01M shares 10-Q · filed 2016-08-04 |
| 2016-04-28 | 113.16M shares 10-Q · filed 2016-05-05 |
| 2016-01-29 | 112.64M shares 10-K · filed 2016-02-29 |
| 2015-10-30 | 100.91M shares 10-Q · filed 2015-11-05 |
| 2015-07-31 | 100.71M shares 10-Q · filed 2015-08-06 |
| 2015-04-30 | 100.30M shares 10-Q · filed 2015-05-07 |
| 2015-01-30 | 100.17M shares 10-K · filed 2015-02-26 |
| 2014-10-31 | 99.77M shares 10-Q · filed 2014-11-10 |
| 2014-07-31 | 99.44M shares 10-Q · filed 2014-08-05 |
| 2014-04-30 | 98.98M shares 10-Q · filed 2014-05-06 |
| 2014-01-31 | 91.35M shares 10-K · filed 2014-02-27 |
| 2013-10-31 | 90.87M shares 10-Q · filed 2013-11-06 |
| 2013-07-31 | 88.78M shares 10-Q · filed 2013-08-06 |
| 2013-04-29 | 79.16M shares 10-Q · filed 2013-05-07 |
| 2013-03-01 | 78.76M shares 10-K · filed 2013-03-12 |
| 2012-10-31 | 56.62M shares 10-Q · filed 2012-11-05 |
| 2012-07-31 | 53.03M shares 10-Q · filed 2012-08-08 |
| 2012-04-30 | 52.93M shares 10-Q · filed 2012-05-08 |
| 2012-03-01 | 52.90M shares 10-K · filed 2012-03-06 |
| 2011-10-31 | 52.80M shares 10-Q · filed 2011-11-09 |
| 2011-07-31 | 52.80M shares 10-Q · filed 2011-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |